From May 5–7, LivGemini exhibited at MedtecLIVE 2026 in Stuttgart, one of Europe’s key meeting points for the medical technology industry.

At our booth, we presented how LivGemini combines AI, computational modelling and patient-specific Digital Twins to support the development and evaluation of cardiovascular medical devices.

Our technology aims to help manufacturers move beyond conventional design and testing workflows by enabling devices to be assessed across patient-specific anatomies and virtual populations, exploring how different designs and configurations interact with real anatomical variability.

This creates new opportunities to support device design, performance evaluation, in-silico testing and pre-clinical development, while reducing the time and manual effort required to build complex computational models.

MedtecLIVE was also an important opportunity to engage directly with device manufacturers, engineering teams and technology partners and discuss how simulation and Digital Twins can become practical tools throughout the medical device development lifecycle.

From patient-specific anatomy to virtual device testing, LivGemini is bringing computational medicine closer to the MedTech industry.